insights_auto
Why is INO down ၄.၁၃%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
၁.၁၆ US$
arrow_downward
-၄.၁၃%(-၀.၀၅၀) 1D
၁.၁၈ US$
arrow_upward
+၁.၆၆% (+၀.၀၁၉)bedtimeAfter hours
Closed: အောက် ၂, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
၁.၂၂ US$
High
၁.၂၃ US$
Low
၁.၁၆ US$
Mkt. cap
၁၁.၉၉ ကုဋေ
Avg. vol.
၃.၁၂ သန်း
Volume
၂.၉၂ သန်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၇ US$
EPS
-၁.၁၇ US$
Beta
၁.၆၁
Shares outstanding
၁၀.၃၄ ကုဋေ
No. of employees
၁၁၂
Open
၁.၂၂ US$
High
၁.၂၃ US$
Low
၁.၁၆ US$
Mkt. cap
၁၁.၉၉ ကုဋေ
Avg. vol.
၃.၁၂ သန်း
Volume
၂.၉၂ သန်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၇ US$
EPS
-၁.၁၇ US$
Beta
၁.၆၁
Shares outstanding
၁၀.၃၄ ကုဋေ
No. of employees
၁၁၂
News stories
From web sources and news partners
AD HOC NEWS
·
ပြီးခဲ့သည့် ၁၁ နာရီ
MarketBeat cites a USD 3.17 target for Inovio Pharmaceuticals stock
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc